You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Focused investments in the cards for Flerie
Text:
Kim Liedholm | [email protected]
Life science investor Flerie reports a net asset value of SEK 3,918 million at the end of the third quarter, corresponding to SEK 50,58 per share – a decrease of 4,2 percent compared to Q2. At the same time...